Loading…
Bluejay Diagnostics, Inc. is projected to decline to $1.44 by 2027, a -1% move from its current price of $1.45. BJDX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.31 | $1.45 | $1.60 | -0.05% |
| Jul 14 | $1.26 | $1.45 | $1.67 | -0.11% |
| Jul 15 | $1.22 | $1.45 | $1.72 | -0.16% |
| Jul 16 | $1.18 | $1.45 | $1.77 | -0.21% |
| Jul 17 | $1.15 | $1.45 | $1.81 | -0.26% |
| Jul 18 | $1.13 | $1.45 | $1.85 | -0.32% |
| Jul 19 | $1.11 | $1.44 | $1.89 | -0.37% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.11 | $1.44 | $1.89 | -0.37% |
| Week 2 | $0.9872 | $1.44 | $2.10 | -0.74% |
| Week 3 | $0.9036 | $1.43 | $2.28 | -1.10% |
| Week 4 | $0.8382 | $1.43 | $2.44 | -1.47% |
| Week 5 | $0.7842 | $1.42 | $2.58 | -1.83% |
| Week 6 | $0.738 | $1.42 | $2.73 | -2.19% |
| Week 7 | $0.6978 | $1.41 | $2.86 | -2.55% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers the Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force.
The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform.
Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Bluejay Diagnostics, Inc. (BJDX) currently trades at $1.45 per share with a market capitalization of $1.5M, ranking 5437.
The stock trades in a highly volatile environment with annualized volatility of 200%.
Bearish sentiment is reflected in the technical readings, with RSI14 at 30 and moving averages at SMA50 $2.66 and SMA200 $3.89.
Near-term levels show support at $1.14 and resistance at $5.30, and the 30-day range spans from $0.7462 to $2.82.
A major floor 21.4% below — a decisive break under it would weaken the trend.
The nearest floor, 21.4% below — buyers have tended to step in here.
The nearest ceiling, 265.5% above — a clean break opens room to run.
A major ceiling 368.3% above — clearing it would confirm fresh momentum.
Key BJDX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BJDX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.36 | Buy | $1.43 | Buy |
| MA 10 | $1.47 | Sell | $1.73 | Sell |
| MA 20 | $2.83 | Sell | $2.29 | Sell |
| MA 50 | $2.66 | Sell | $2.59 | Sell |
| MA 100 | $2.31 | Sell | $2.85 | Sell |
| MA 200 | $3.89 | Sell | $27.01 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 34.90 | Neutral |
| Stoch RSI (14) | 25.09 | Neutral |
| CCI (20) | -67.21 | Neutral |
| Williams %R (14) | -88.69 | Info |
| MACD (12,26,9) | -0.21 | Sell |
| ROC (12) | -62.63 | Sell |
| Bollinger %B (20,2) | 0.27 | Neutral |
| Stochastic %K (14) | 11.31 | Buy |
| TRIX (15) | -1.49 | Sell |
| Awesome (5,34) | -1.70 | Sell |
| Ultimate (7,14,28) | 52.13 | Neutral |
| Momentum (10) | -1.86 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 1.42 | Buy |
| ADX (14) | 31.91 | Sell |
| ATR (14) | 0.26 | Info |
The 30-day technical picture for BJDX shows BEARISH sentiment with RSI14 at 30.
The trend indicators position the price below the key moving averages, with SMA50 at $2.66 and SMA200 at $3.89.
Critical support and resistance levels to watch are at $1.14 and $5.30, while the 30-day price range runs from $0.7462 to $2.82.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.14 | $1.45 | $1.81 | 0% | Neutral | |
| $1.04 | $1.44 | $2.14 | -1% | Neutral | |
| $0.9141 | $1.34 | $2.13 | -8% | Neutral | |
| $0.7031 | $1.08 | $1.81 | -25% | Bearish | |
| $0.6739 | $1.09 | $1.89 | -25% | Bearish | |
| $0.8511 | $1.44 | $2.59 | -1% | Neutral | |
| $1.02 | $1.80 | $3.34 | +24% | Bullish | |
| $0.9045 | $1.66 | $3.16 | +15% | Neutral | |
| $0.7664 | $1.46 | $2.86 | +1% | Neutral | |
| $0.7474 | $1.48 | $2.96 | +2% | Neutral | |
| $0.9951 | $2.21 | $4.85 | +53% | Bullish | |
| $1.71 | $3.80 | $8.74 | +162% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.14 | $1.45 | $1.85 | +0.00% |
| August 2026 | $1.23 | $1.49 | $1.88 | +2.72% |
| September 2026 | $1.12 | $1.38 | $1.78 | -7.23% |
| October 2026 | $1.10 | $1.37 | $1.80 | -0.53% |
| November 2026 | $1.12 | $1.41 | $1.87 | +2.43% |
| December 2026 | $1.06 | $1.34 | $1.81 | -4.73% |
Click any year to see its month-by-month BJDX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, BJDX is projected to trade between $1.14 and $1.81, averaging $1.45 — a potential gain of 0% from today's $1.45. A consolidation phase looks the most probable path here.
Bluejay Diagnostics, Inc.'s 2027 outlook centres on $1.44, within a $1.04 to $2.14 range. That is -1% versus the projected 2026 average. That marks a -1% change versus current levels. Price action looks broadly range-bound.
By 2028, BJDX could reach as high as $2.13, with a base case around $1.34 and support toward $0.9141 — roughly -8% from $1.45. A consolidation phase looks the most probable path here.
Expect BJDX to range from $0.7031 to $1.81 through 2029. The $1.08 average target implies a -25% move from current prices. That is -19% versus the projected 2028 average. A cyclical pullback looks likely — prices rarely move in a straight line.
The BJDX price prediction for 2030 points to an average of $1.09 (low $0.6739, high $1.89) — a potential decline of -25% on today's $1.45. Expect choppier, lower action through this leg of the cycle.
In 2031, BJDX is projected to trade between $0.8511 and $2.59, averaging $1.44 — a potential decline of -1% from today's $1.45. That is up +32% on the projected 2030 average. Price action looks broadly range-bound.
Bluejay Diagnostics, Inc.'s 2032 outlook centres on $1.80, within a $1.02 to $3.34 range. That is up +25% on the projected 2031 average. That marks a +24% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, BJDX could reach as high as $3.16, with a base case around $1.66 and support toward $0.9045 — roughly +15% from $1.45. Price action looks broadly range-bound.
Expect BJDX to range from $0.7664 to $2.86 through 2034. The $1.46 average target implies a +1% move from current prices. That is -12% versus the projected 2033 average. A consolidation phase looks the most probable path here.
The BJDX price prediction for 2035 points to an average of $1.48 (low $0.7474, high $2.96) — a potential gain of +2% on today's $1.45. Price action looks broadly range-bound.
In 2040, BJDX is projected to trade between $0.9951 and $4.85, averaging $2.21 — a potential gain of +53% from today's $1.45. That is up +49% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Bluejay Diagnostics, Inc.'s 2050 outlook centres on $3.80, within a $1.71 to $8.74 range. That is up +72% on the projected 2040 average. That marks a +162% change versus current levels. Momentum favours further upside here.
Investing $1,000 in BJDX today (≈ 689.655172 BJDX) could be worth
$2,621.23
+$1,621.23 (+162%) by 2050 · US Dollar
Based on the average projected BJDX price of $3.8 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BJDXwould be worth at today's price.
$1,000 invested in BJDX on Jul 10, 2025 (≈ 151.515154 BJDX) would be worth
$219.7
-$780.3 (-78.0%) today · 0.22× · US Dollar
Based on a BJDX entry price of $6.6 vs. today's $1.45.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.14 | $1,271.93 | +27.2% |
| 1 month ago | $4.49 | $322.94 | -67.7% |
| 3 months ago | $1.78 | $814.61 | -18.5% |
| 6 months ago | $2.6 | $557.69 | -44.2% |
| 1 year ago | $6.6 | $219.7 | -78.0% |
| All time (4.7y) ago | $170,240 | $0.01 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BJDX forecast.
Our base-case forecast reaches $2.90 around 2050.
Implied market cap at $2.90: $3M
The multi-year forecast shows a mix of near-term weakness and longer-term upside.
In 2026 min $1.14, avg $1.45, max $1.81; ROI 0%; sentiment NEUTRAL. In 2027 min $1.04, avg $1.44, max $2.14; ROI -0.8%; sentiment NEUTRAL. In 2028 min $0.9141, avg $1.34, max $2.13; ROI -7.7%; sentiment NEUTRAL. In 2029 min $0.7031, avg $1.08, max $1.81; ROI -25.2%; sentiment BEARISH. In 2030 min $0.6739, avg $1.09, max $1.89; ROI -24.8%; sentiment BEARISH.
The forecast then bends toward a bullish stance in 2032 with min $1.02, avg $1.80, max $3.34; ROI 24.2%; sentiment BULLISH. 2033 shows min $0.9045, avg $1.66, max $3.16; ROI 14.6%; sentiment NEUTRAL. 2034 has min $0.7664, avg $1.46, max $2.86; ROI 1%; sentiment NEUTRAL. 2035 presents min $0.7474, avg $1.48, max $2.96; ROI 2.4%; sentiment NEUTRAL.
The trajectory turns more clearly bullish by 2040 with min $0.9951, avg $2.21, max $4.85; ROI 52.5%; sentiment BULLISH. By 2050 the forecast shows min $1.71, avg $3.80, max $8.74; ROI 162.1%; sentiment BULLISH.
Tap a question to reveal the answer.
2030 avg $1.09; min $0.6739; max $1.89; ROI -24.8%; sentiment BEARISH.
Forecasts show mixed results: near-term years (2026-2031) are largely NEUTRAL to BEARISH with negative ROI in 2029 and 2030, followed by longer-term upside with positive ROI, including 24.2% in 2032, 52.5% in 2040, and 162.1% in 2050; these are estimates, not guarantees.
The forecast shows a max price of $3.34 in 2032, $3.16 in 2033, $4.85 in 2040, and $8.74 in 2050. This indicates the potential to exceed $5 by 2050.
Current price is $1.45 and market cap is $1.5M.
2040 min $0.9951, avg $2.21, max $4.85; ROI 52.5%; sentiment BULLISH.
Bluejay Diagnostics, Inc. Community Discussion
0Share your Bluejay Diagnostics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.